Gossamer Bio Inc
GOSS
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.82M
Close$
$0.11
34.5% downside
Current Fair Value
34.5% downsideOvervalued by 34.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $36.82 Million |
|---|---|
| Enterprise Value | $197.77 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 2.01 |
| Outstanding Shares | 234,137,364 |
Return
| Return on Equity | 111.71% |
|---|---|
| Return on Assets | -139.95% |
| Return on Invested Capital | -242.49% |
Valuation & Multiples
| P/E Ratio | -0.2 |
|---|---|
| PEG | -0.73 |
| Price to Sales | - |
| Price to Book Ratio | -0.17 |
| Enterprise Value to Revenue | 3.56 |
| Enterprise Value to EBIT | -1.13 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -1.25 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$4.67 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$4.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1819▼ 14.36% |
|---|---|
| Total Calls | 2,843,300▼ 53.69% |
| Total Puts | 517,300▼ 74.12% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 73.09%▼ 8.05% |
|---|---|
| Total Invested | $55.40M▼ 90.34% |
| Investors Holding | 198▼ 19.00% |
ESG Score
No data
About Gossamer Bio Inc
CEO: Sheila Gujrathi